2026 Global: Microneedle Drug Delivery Systems Market-Competitive Review (2032) report
Description
The 2026 Global: Microneedle Drug Delivery Systems Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
The microneedle drug delivery systems market features prominent companies driving innovation in painless, transdermal drug administration for vaccines, biologics, and therapeutics. Leading players include 3M Company, headquartered in St. Paul, Minnesota, USA, which develops solid microneedle patches and transdermal systems with global R&D hubs. Becton, Dickinson and Company (BD), based in Franklin Lakes, New Jersey, USA, leverages automation for high-speed microneedle production and inspection, emphasizing quality in drug delivery devices. Nitto Denko Corporation, located in Osaka, Japan, specializes in advanced polymer-based microneedles for efficient transdermal release. Zosano Pharma Corporation, in Fremont, California, USA, focuses on microneedle arrays for rapid systemic drug delivery, particularly for migraines and vaccines. Corium International, Inc., headquartered in Grand Rapids, Michigan, USA (acquired by Gurnet Point Capital), pioneers dissolvable microneedle patches for therapeutics like contraceptives.
Additional key firms expand the market's scope through specialized technologies. Nanopass Technologies Ltd., based in Nes Ziona, Israel, offers the MicronJet® hollow microneedle device for precise intradermal delivery of vaccines and biologics. Raphas Co. Ltd., situated in Seoul, South Korea, develops biodegradable microneedle patches for sustained drug release, targeting vaccines and hormones. Microdermics, headquartered in Vancouver, Canada, commercializes hollow microneedle platforms to disrupt traditional injections in biotherapeutics. Kindeva Drug Delivery, located in St. Paul, Minnesota, USA, provides end-to-end microneedle patch manufacturing, partnering on scalable vaccine solutions. AdminMed nanoBioSciences LLC, in Raleigh, North Carolina, USA, advances the AdminPatch® for minimally invasive delivery of proteins and cosmetics.
These companies collectively fuel market growth from $5.01 billion in 2024 to projected $9.1 billion by 2027, driven by patents, collaborations, and manufacturing scalability. Sorrento Therapeutics, based in San Diego, California, USA, leads in lymphatic microneedle patents via Sofusa acquisition, targeting oncology like Ipilimumab delivery. Innovations address patient compliance, with firms like LTS Lohmann Therapie-Systeme AG in Andernach, Germany, enhancing patch-based systems. Challenges include regulatory hurdles and scaling, yet leaders prioritize precision dispensing and biocompatibility for clinical adoption across vaccines, hormones, and chronic therapies. This competitive landscape underscores a shift toward needle-free alternatives, benefiting global healthcare accessibility.
The microneedle drug delivery systems market features prominent companies driving innovation in painless, transdermal drug administration for vaccines, biologics, and therapeutics. Leading players include 3M Company, headquartered in St. Paul, Minnesota, USA, which develops solid microneedle patches and transdermal systems with global R&D hubs. Becton, Dickinson and Company (BD), based in Franklin Lakes, New Jersey, USA, leverages automation for high-speed microneedle production and inspection, emphasizing quality in drug delivery devices. Nitto Denko Corporation, located in Osaka, Japan, specializes in advanced polymer-based microneedles for efficient transdermal release. Zosano Pharma Corporation, in Fremont, California, USA, focuses on microneedle arrays for rapid systemic drug delivery, particularly for migraines and vaccines. Corium International, Inc., headquartered in Grand Rapids, Michigan, USA (acquired by Gurnet Point Capital), pioneers dissolvable microneedle patches for therapeutics like contraceptives.
Additional key firms expand the market's scope through specialized technologies. Nanopass Technologies Ltd., based in Nes Ziona, Israel, offers the MicronJet® hollow microneedle device for precise intradermal delivery of vaccines and biologics. Raphas Co. Ltd., situated in Seoul, South Korea, develops biodegradable microneedle patches for sustained drug release, targeting vaccines and hormones. Microdermics, headquartered in Vancouver, Canada, commercializes hollow microneedle platforms to disrupt traditional injections in biotherapeutics. Kindeva Drug Delivery, located in St. Paul, Minnesota, USA, provides end-to-end microneedle patch manufacturing, partnering on scalable vaccine solutions. AdminMed nanoBioSciences LLC, in Raleigh, North Carolina, USA, advances the AdminPatch® for minimally invasive delivery of proteins and cosmetics.
These companies collectively fuel market growth from $5.01 billion in 2024 to projected $9.1 billion by 2027, driven by patents, collaborations, and manufacturing scalability. Sorrento Therapeutics, based in San Diego, California, USA, leads in lymphatic microneedle patents via Sofusa acquisition, targeting oncology like Ipilimumab delivery. Innovations address patient compliance, with firms like LTS Lohmann Therapie-Systeme AG in Andernach, Germany, enhancing patch-based systems. Challenges include regulatory hurdles and scaling, yet leaders prioritize precision dispensing and biocompatibility for clinical adoption across vaccines, hormones, and chronic therapies. This competitive landscape underscores a shift toward needle-free alternatives, benefiting global healthcare accessibility.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
